Vanda Pharmaceuticals (VNDA) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to -$31.8 million.
- Vanda Pharmaceuticals' Free Cash Flow fell 11562.2% to -$31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.0 million, marking a year-over-year decrease of 35575.52%. This contributed to the annual value of -$16.2 million for FY2024, which is 23083.43% down from last year.
- Per Vanda Pharmaceuticals' latest filing, its Free Cash Flow stood at -$31.8 million for Q3 2025, which was down 11562.2% from -$15.6 million recorded in Q2 2025.
- In the past 5 years, Vanda Pharmaceuticals' Free Cash Flow ranged from a high of $31.8 million in Q1 2023 and a low of -$33.6 million during Q1 2025
- For the 5-year period, Vanda Pharmaceuticals' Free Cash Flow averaged around $537736.8, with its median value being $4.0 million (2022).
- Per our database at Business Quant, Vanda Pharmaceuticals' Free Cash Flow soared by 80804.69% in 2021 and then tumbled by 61080.04% in 2024.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Free Cash Flow stood at $26.5 million in 2021, then crashed by 65.43% to $9.2 million in 2022, then plummeted by 143.54% to -$4.0 million in 2023, then skyrocketed by 49.03% to -$2.0 million in 2024, then plummeted by 1465.09% to -$31.8 million in 2025.
- Its Free Cash Flow was -$31.8 million in Q3 2025, compared to -$15.6 million in Q2 2025 and -$33.6 million in Q1 2025.